Toward Enhanced Machine-Based Release in X-ray Sterilization.

Trends toward the use of irradiator parameter release (also called machine-based release) put pressure on equipment manufacturers to guarantee accuracy and reliability of monitored process parameters. In the specific case of X-ray processing, relevance of these monitored parameters is questionable due to the additional difficulty coming from the fact that the X-ray converter does not have associated parameters or a monitored feedback mechanism. To bridge this gap, this article presents a novel method to verify in real-time consistency of certain X-ray field properties. It covers the description of an X-ray flux monitor and its experimental characterization. The proposed detector can be used as a control and monitoring tool in addition to the conventional "passive" dosimetry per ISO 11137-1 and ISO 11137-3. It can detect photon flux deviation on the order of magnitude of 1%. Its performance would allow real-time monitoring of each pallet being processed and ensure that the correct X-ray beam is directed to the product. Further, the known response of the detector to a product can serve as a validation that the correct product is in front of the beam. Moreover, a detector of this type could contribute to moving from the current dosimetric release to irradiator parameter release. Compared with current practices, benefits would include an increased number of control points used to verify process conformity, real-time information on the radiation field (process output validation), limited manual handling of dosimeters, and verification that the product treated is the same as the performance qualification dose-mapped product.

Reliability of isokinetic tests of velocity- and contraction intensity-dependent plantar flexor mechanical properties.

"Flexibility" tests are traditionally performed voluntarily relaxed by rotating a joint slowly; however, functional activities are performed rapidly with voluntary/reflexive muscle activity. Here, we describe the reliabilities and differences in maximum ankle range of motion (ROMmax ) and plantar flexor mechanical properties at several velocities and levels of voluntary force from a new test protocol on a commercially available dynamometer. Fifteen participants had their ankle joint dorsiflexed at 5, 30, and 60° s-1 in two conditions: voluntarily relaxed and while producing 40% and 60% of maximal eccentric torque. Commonly reported variables describing ROMmax and resistance to stretch were subsequently calculated from torque and angle data. Absolute (coefficient of variation (CV%) and typical error) and relative (ICC2,1 ) reliabilities were determined across two testing days (≥72 h). ROMmax relative reliability was good in voluntarily relaxed tests at 30 and 60° s-1 and moderate at 5° s-1 , despite CVs ≤ 10% for all velocities. Tests performed with voluntary muscle activity were only reliable when performed at 5° s-1 , and ROMmax reliability was moderate and CV ≤ 8%. For most variables, the rank order of participants differed between the slow-velocity, relaxed test, and those performed at faster speeds or with voluntary activation, indicating different information. A person's flexibility status during voluntarily relaxed fast or active stretches tended to differ from their status in the traditional voluntarily relaxed, slow-velocity test. Thus, "flexibility" tests should be completed under conditions of different stretch velocity and levels of muscle force production, and clinicians and researchers should consider the slightly larger between-day variability from slow-velocity voluntarily relaxed tests.

A probabilistic risk assessment approach used to prioritize chemical constituents in mainstream smoke of cigarettes sold in China.

The chemical and physical complexity of cigarette mainstream smoke (MSS) presents a challenge in the understanding of risk for smoking-related diseases. Quantitative risk assessment is a useful tool for assessing the toxicological risks that may be presented by smoking currently available commercial cigarettes. In this study, yields of a selected group of chemical constituents were quantified in machine-generated MSS from 30 brands of cigarettes sold in China. Using constituent yields, exposure estimates specific to and representative of the Chinese population, and available dose-response data, a Monte Carlo method was applied to simulate probability distributions for incremental lifetime cancer risk (ILCR), hazard quotient (HQ), and margin of exposure (MOE) values for each constituent as appropriate. Measures of central tendency were extracted from the outcome distributions and constituents were ranked according to these three risk assessment indices. The constituents for which ILCR >10(-4), HQ >1, and MOE <10,000 included acetaldehyde, acrylonitrile, benzene, cadmium, formaldehyde, and pyridine. While limitations exist to this methodology in estimating the absolute magnitude of health risk contributed by each MSS constituent, this approach provides a plausible and objective framework for the prioritization of toxicants in cigarette smoke and is valuable in guiding tobacco risk management.

Arsenic exposure and tobacco consumption: Biomarkers and risk assessment.

Arsenic is measurable in tobacco and cigarette mainstream smoke (MSS). Whether arsenic has an independent role in diseases associated with tobacco consumption is not known. Epidemiology and biomonitoring data and probabilistic risk assessment (PRA) methods were used to investigate this potential association. Analysis of data from the National Health and Nutrition Examination Survey (NHANES) showed that urine arsenic concentrations in tobacco consumers were not different or were lower than levels in non-consumers of tobacco. Additionally, urine arsenic levels from NHANES tobacco consumers were five-times or more lower than levels reported in epidemiology studies to be associated with adverse health effects. Results of PRA indicated that mean non-cancer hazard estimates and mean incremental lifetime cancer risk estimates were within accepted ranges. Taken together, these results suggest that arsenic may not be independently associated with tobacco consumption or diseases related to tobacco consumption.

Cadmium exposure and tobacco consumption: Biomarkers and risk assessment.

To investigate whether cadmium has an independent role in diseases associated with tobacco consumption, epidemiology data were reviewed, biomonitoring data were analyzed, and probabilistic risk assessment (PRA) was performed. Results from previous epidemiology studies have indicated that there are adverse health effects potentially in common between cadmium exposure and tobacco consumption. Analysis of publically available biomonitoring data showed that blood (B-Cd) and urine (U-Cd) cadmium were higher in cigarette smokers compared with smokeless tobacco (SLT) consumers, and B-Cd and U-Cd in SLT consumers were not significantly different than in non-consumers of tobacco. Comparison with previously established biomonitoring equivalent (BE) values indicated that B-Cd and U-Cd in the majority of these cigarette smokers and SLT consumers did not exceed the blood and urine BEs. Results of the PRA showed that the mean hazard estimate was below a generally accepted regulatory threshold for SLT consumers, but not for cigarette smokers. In total, this evaluation indicated that cadmium exposures in tobacco consumers differed by product category consumed; cadmium in tobacco may not be associated with tobacco consumption related diseases; if cadmium in tobacco contributes to tobacco consumption related diseases, differences in hazard and/or risk may exist by product category.

Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999-2008.

Assessment of biomarkers is an appropriate way to estimate exposure to cigarette mainstream smoke and smokeless tobacco (SLT) constituents in tobacco consumers. Using the US National Health and Nutrition Examination Survey (NHANES, 1999-2008), biomarkers of volatile organic compounds, halogenated aromatic hydrocarbons (HAHs), polycyclic aromatic hydrocarbons (PAHs), acrylamide, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and metals were evaluated. In general, biomarker levels in SLT consumers were significantly lower than in smokers (excluding NNK and some HAHs) and were not significantly different compared with nonconsumers (excluding NNK and some PAHs). These results provide useful information for science-based risk assessment and regulation of tobacco products.

A chemical structure-based approach for estimating the added levels of flavourings to foods for the purpose of assessing consumer intake.

Intake assessment and hazard profile of chemical substances are the two critical inputs in a safety assessment. Human intake assessment presents challenges that stem either from the absence of data or from numerous sources of variability and uncertainty, which have led regulators to adopt conservative approaches that inevitably overestimate intake. Refinements of intake assessments produce more realistic estimates and help prioritise areas of concern and better direct investment of resources. However, use levels (ULs), which represent the usual added amount of flavourings to food products, are the starting point for refined intake assessments, are data-intensive, and data availability is often a limitation. The work presented here was undertaken to investigate the use level patterns of substances used as flavourings in foods and to develop a systematic tool for data extrapolation based on chemical structure. The available dataset consists of use levels reported through eight industry surveys and hence are representative of industry uses rather than regulatory limits, which are higher by design and not realistic. A systematic statistical analysis was undertaken to determine whether the industry-reported UL data can be used to estimate use levels of flavouring substances belonging to the same chemical group for which such data are not available. Predictive modelling approaches were explored to evaluate relationships in the data and utilised additional variables relevant to technological considerations, such as volatility losses upon heat treatment, and Tanimoto index-based pair-wise structural similarity scores to determine whether more granular similarity information can reduce the within-group variability. The analyses indicated that the use levels of flavouring substances can reasonably be estimated based on the available data using chemical group classifications stratified by food category. Source of uncertainty and limitations are discussed.

A Bayesian statistical analysis of mouse dermal tumor promotion assay data for evaluating cigarette smoke condensate.

The mouse dermal assay has long been used to assess the dermal tumorigenicity of cigarette smoke condensate (CSC). This mouse skin model has been developed for use in carcinogenicity testing utilizing the SENCAR mouse as the standard strain. Though the model has limitations, it remains as the most relevant method available to study the dermal tumor promoting potential of mainstream cigarette smoke. In the typical SENCAR mouse CSC bioassay, CSC is applied for 29 weeks following the application of a tumor initiator such as 7,12-dimethylbenz[a]anthracene (DMBA). Several endpoints are considered for analysis including: the percentage of animals with at least one mass, latency, and number of masses per animal. In this paper, a relatively straightforward analytic model and procedure is presented for analyzing the time course of the incidence of masses. The procedure considered here takes advantage of Bayesian statistical techniques, which provide powerful methods for model fitting and simulation. Two datasets are analyzed to illustrate how the model fits the data, how well the model may perform in predicting data from such trials, and how the model may be used as a decision tool when comparing the dermal tumorigenicity of cigarette smoke condensate from multiple cigarette types. The analysis presented here was developed as a statistical decision tool for differentiating between two or more prototype products based on the dermal tumorigenicity.

Effects of Resistance Training Movement Pattern and Velocity on Isometric Muscular Rate of Force Development: A Systematic Review with Meta-analysis and Meta-regression.

BACKGROUND: Muscular rate of force development (RFD) is positively influenced by resistance training. However, the effects of movement patterns and velocities of training exercises are unknown. OBJECTIVES: To determine the effects of velocity, the intent for fast force production, and movement pattern of training exercises on the improvement in isometric RFD from chronic resistance training. METHODS: A systematic search of electronic databases was conducted to 18 September, 2018. Meta-regression and meta-analytic methods were used to compute standardized mean differences (SMD ± 95% confidence intervals) to examine effects of movement pattern similarity (between training and test exercises; specific vs. non-specific) and movement speed (fast vs. slow vs. slow with intent for fast force production) for RFD calculated within different time intervals. RESULTS: The search yielded 1443 articles, of which 54 met the inclusion criteria (59 intervention groups). Resistance training increased RFD measured to both early (e.g., 50 ms; standardized mean difference [95% CI] 0.58 [0.40, 0.75]) and later (e.g., 200 ms; 0.39 [0.25, 0.52]) times from contraction onset, as well as maximum RFD (RFDmax; 0.35 [0.21, 0.48]). However, sufficient data for sub-analyses were only available for RFDmax. Significant increases relative to control groups were observed after training with high-speed (0.54 [0.05, 1.03]), slow-speed with intent for fast force production (0.41 [0.20, 0.63), and movement pattern-specific (0.38 [0.17, 0.59]) exercises only. No clear effect was observed for slow-speed without intent for fast force production (0.21 [0.00, 0.42], p = 0.05) or non-movement-specific (0.27 [- 0.32, 0.85], p = 0.37) exercises. Meta-regression did not reveal a significant difference between sexes (p = 0.09); however, a negative trend was found in women (- 0.57 [- 1.51, 0.37], p = 0.23), while a favorable effect was found in men (0.40 [0.22, 0.58], p < 0.001). Study duration did not statistically influence the meta-analytic results, although the greatest RFD increases tended to occur within the first weeks of the commencement of training. CONCLUSIONS: Resistance training can evoke significant increases in RFD. For maximum (peak) RFD, the use of faster movement speeds, the intention to produce rapid force irrespective of actual movement speed, and similarity between training and testing movement patterns evoke the greatest improvements. In contrast to expectation, current evidence indicates a between-sex difference in response to training; however, a lack of data in women prevents robust analysis, and this should be a target of future research. Of interest from a training program design perspective was that RFD improvements were greatest within the first weeks of training, with less ongoing improvement (or a reduction in RFD) with longer training, particularly when training velocity was slow or there was a lack of intent for fast force production.

The effect of isokinetic dynamometer deceleration phase on maximum ankle joint range of motion and plantar flexor mechanical properties tested at different angular velocities.

During range of motion (max-ROM) tests performed on an isokinetic dynamometer, the mechanical delay between the button press (by the participant to signal their max-ROM) and the stopping of joint rotation resulting from system inertia induces errors in both max-ROM and maximum passive joint moment. The present study aimed to quantify these errors by comparing data when max-ROM was obtained from the joint position data, as usual (max-ROMPOS), to data where max-ROM was defined as the first point of dynamometer arm deceleration (max-ROMACC). Fifteen participants performed isokinetic ankle joint max-ROM tests at 5, 30 and 60° s-1. Max-ROM, peak passive joint moment, end-range musculo-articular (MAC) stiffness and area under the joint moment-position curve were calculated. Greater max-ROM was observed in max-ROMPOS than max-ROMACC (P < 0.01) at 5 (0.2 ±â€¯0.15%), 30 (1.8 ±â€¯1.0%) and 60° s-1 (5.9 ±â€¯2.3%), with the greatest error at the fastest velocity. Peak passive moment was greater and end-range MAC stiffness lower in max-ROMPOS than in max-ROMACC only at 60° s-1 (P < 0.01), whilst greater elastic energy storage was found at all velocities. Max-ROM and peak passive moment are affected by the delay between button press and eventual stopping of joint rotation in an angular velocity-dependent manner. This affects other variables calculated from the data. When high data accuracy is required, especially at fast joint rotation velocities (≥30° s-1), max-ROM (and associated measures calculated from joint moment data) should be taken at the point of first change in acceleration rather than at the dynamometer's ultimate joint position.

Adipocyte-Specific GH Receptor-Null (AdGHRKO) Mice Have Enhanced Insulin Sensitivity With Reduced Liver Triglycerides.

Global GH receptor-null or knockout (GHRKO) mice have been extensively studied owing to their unique phenotype (dwarf and obese but remarkably insulin sensitive and long-lived). To better understand the influence of adipose tissue (AT) on the GHRKO phenotype, we previously generated fat-specific GHRKO (FaGHRKO) mice using the adipocyte protein-2 (aP2) promoter driving Cre expression. Unlike global GHRKO mice, FaGHRKO mice are larger than control mice and have an increase in white AT (WAT) mass and adipocyte size as well as an increase in brown AT mass. FaGHRKO mice also have an unexpected increase in IGF-1, decrease in adiponectin, no change in insulin sensitivity or liver triglyceride content, and a decreased lifespan. Extensive analysis of the aP2 promoter/enhancer by multiple laboratories has revealed expression in nonadipose tissues, confounding interpretation of results. In the current study, we used the adiponectin promoter/enhancer to drive Cre expression, which better targets mature adipocytes, and generated a new line of adipocyte-specific GHRKO (AdGHRKO) mice. AdGHRKO mice have an increase in adipocyte size and WAT depot mass in all depots except male perigonadal, a WAT accumulation pattern similar to FaGHRKO mice. Likewise, adiponectin levels and WAT fibrosis are decreased in both tissue-specific mouse lines. However, unlike FaGHRKO mice, AdGHRKO mice have no change in IGF-1 levels, improved glucose homeostasis, and reduced liver triglycerides. Thus, AdGHRKO mice should be valuable for future studies assessing the contribution of adipocyte GHR signaling in long-term health and lifespan.

Increased fibrosis: A novel means by which GH influences white adipose tissue function.

OBJECTIVE: White adipose tissue (WAT) fibrosis - the buildup of extracellular matrix (ECM) proteins, primarily collagen - is now a recognized hallmark of tissue dysfunction and is increased with obesity and lipodystrophy. While growth hormone (GH) is known to increase collagen in several tissues, no previous research has addressed its effect on ECM in WAT. Thus, the purpose of this study is to determine if GH influences WAT fibrosis. DESIGN: This study examined WAT from four distinct strains of GH-altered mice (bGH and GHA transgenic mice as well as two tissue specific GH receptor gene disrupted lines, fat growth hormone receptor knockout or FaGHRKO and liver growth hormone receptor knockout or LiGHRKO mice). Collagen content and adipocyte size were studied in all cohorts and compared to littermate controls. In addition, mRNA expression of fibrosis-associated genes was assessed in one cohort (6month old male bovine GH transgenic and WT mice) and cultured 3T3-L1 adipocytes treated with GH. RESULTS: Collagen stained area was increased in WAT from bGH mice, was depot-dependent, and increased with age. Furthermore, increased collagen content was associated with decreased adipocyte size in all depots but more dramatic changes in the subcutaneous fat pad. Notably, the increase in collagen was not associated with an increase in collagen gene expression or other genes known to promote fibrosis in WAT, but collagen gene expression was increased with acute GH administration in 3T3-LI cells. In contrast, evaluation of 6month old GH antagonist (GHA) male mice showed significantly decreased collagen in the subcutaneous depot. Lastly, to assess if GH induced collagen deposition directly or indirectly (via IGF-1), fat (Fa) and liver (Li) specific GHRKO mice were evaluated. Decreased fibrosis in FaGHRKO and increased fibrosis in LiGHRKO mice suggest GH is primarily responsible for the alterations in collagen. CONCLUSIONS: Our results show that GH action is positively associated with an increase in WAT collagen content as well as a decrease in adipocyte size, particularly in the subcutaneous depot. This effect appears to be due to GH and not IGF-1 and reveals a novel means by which GH regulates WAT accumulation.

Mechanism of 24,25-dihydroxyvitamin D3-mediated inhibition of rapid, 1,25-dihydroxyvitamin D3-induced responses: role of reactive oxygen species.

In intestine, 24,25(OH)(2)D(3), which is made under conditions of calcium-, phosphate-, and 1,25(OH)(2)D(3) sufficiency, inhibits the stimulatory actions of 1,25(OH)(2)D(3) on phosphate and calcium absorption. In the current work, we provide evidence that 24,25(OH)(2)D(3)-mediated signal transduction occurs mechanistically through increased H(2)O(2) production which involves binding of 24,25(OH)(2)D(3) to catalase and resultant decreases in enzyme activity. Physiological levels of H(2)O(2) mimicked the action of 24,25(OH)(2)D(3) on inhibiting 1,25(OH)(2)D(3)-stimulated phosphate uptake in isolated enterocytes. Moreover, the molecular basis of such inhibition was suggested by the presence of two thioredoxin domains in the 1,25D(3)-MARRS protein/ERp57: Exposure of cells to either 24,25(OH)(2)D(3) or H(2)O(2) gradually reduced 1,25(OH)(2)D(3) binding to 1,25D(3)-MARRS protein, between 10 and 20 min of incubation, but not to VDR. Feeding studies with diets enriched in the antioxidants vitamins C and E showed that net phosphate absorption in vivo nearly doubled relative to chicks on control diet. Antioxidant diets also resulted in increased [(3)H]1,25(OH)(2)D(3) binding to both 1,25D(3)-MARRS and VDR, suggesting benefits to both transcription- and membrane-initiated signaling pathways. Intriguingly, phosphorous content of bones from birds on antioxidant diets was reduced, suggesting increased osteoclast activity. Because mature osteoclasts lack VDR, we analyzed a clonal osteoclast cell line by RT-PCR and found it contained the 1,25D(3)-MARRS mRNA. The combined data provide mechanistic details for the 1,25(OH)(2)D(3)/24,25(OH)(2)D(3) endocrine system, and point to a role for the 1,25D(3)-MARRS protein as a redox-sensitive mediator of osteoclast activity and potential therapeutic target.

Radio frequency chaff: the effects of its use in training on the environment.

Chaff is a radiofrequency countermeasure released by military aircraft, ships, and vehicles to confuse enemy radar. Chaff consists of aluminum-coated glass fibers ranging in lengths from 0.8 to 0.75 cm and is released in packets of 0.5 to 100 million fibers. The Department of Defense has determined that use of chaff in training is required for maintaining proficiency in the use of this countermeasure. At least 500 tons of chaff is released annually during training within selected military operating areas in the United States. Concerns have been raised about impact on the environment and its potential toxicity to humans, livestock, and wildlife. Many of these concerns have been addressed or are being researched by the Department of Defense and other agencies, but much of the data are unpublished. Herein, the authors summarize the issues and review scientific data for the impact of chaff use on humans, animals, and the environment.

Effect of Navy chaff release on aluminum levels in an area of the Chesapeake Bay.

The U.S. Navy uses aluminized glass chaff as a passive countermeasure for radar-guided threats to aircraft and surface ships. Over the last 25 years, several hundred thousand pounds of aluminized chaff have been released during flight operations over a training area on the Chesapeake Bay. There is concern that these releases have resulted in the accumulation of significant amounts of aluminum in the soil and sediment of this training area. This study compares the exchangeable and monomeric aluminum content of sediment within the affected area with that of samples taken from outside the training area. We found a less than twofold increase in the content of organic monomeric aluminum in samples taken from the affected area versus background samples, whereas inorganic monomeric aluminum concentrations within the affected area were significantly lower than background. These results suggest that chaff releases have not resulted in a significant accumulation of aluminum in this training area.

Assessment of the aquatic and terrestrial toxicity of five biodegradable polymers.

Radiofrequency countermeasures (i.e., chaff) may be released by fighter jets during tactical countermeasures training. Chaff cartridges, pistons, and endcaps (i.e., chaff dispenser materials), all currently made of styrene, are also released into the environment. Accumulation of chaff dispenser materials in the environment is a concern of the Department of Defense. The US Navy is exploring the possibility of constructing degradable chaff dispenser components made of biodegradable polymers. Five polymers are being considered. Degradability and toxicity tests are two of several criteria being used to evaluate various available biodegradable options. Dissolution products from four of five polymers being considered were toxic to aquatic organisms with LC50s/LOELs ranging between 1.24 and 731.30 mg total organic concentration/L. Supernatant from dissolving a 90:10 polyester amide/polyvinyl alcohol copolymer in water for 24h inhibited shoot growth of Brassica rappa and Lepidium sativum. Since our results were obtained using fractions of saturated degradable polymer solutions (1 or 10 g/L), we conclude that the tested degradable polymers were of low toxicity to the seven aquatic organisms and two terrestrial plant species used in our assays. However, our characterization of the toxicity of these degradable polymers may not be applicable to all species or environmental situations. Information gained from these studies will be used for making decisions on which polymers should be used in the engineering of environmentally friendly chaff dispenser cartridges, pistons, and endcaps.